Skip to content

Gene Therapy for SynGAP1 Deficiency

Treatment for the cause of MRD5 intellectual disability with epilepsy

Published: 9th March 2021
Gene Therapy for SynGAP1 Deficiency
Anusorn, https://stock.adobe.com/uk/221688752, stock.adobe.com
IP Status
  • Know-how based
Seeking
  • Development partner
  • Commercial partner
  • Seeking investment
  • University spin out
  • Licensing